Evidence map›Paper›PMID 34047695›Full record

ArticleeLife2021

Inflammation drives alternative first exon usage to regulate immune genes including a novel iron-regulated isoform of

Elektra K Robinson, Pratibha Jagannatha, Sergio Covarrubias, Matthew Cattle, Valeriya Smaliy, Rojin Safavi, Barbara Shapleigh, Robin Abu-Shumays, Miten Jain, Suzanne M Cloonan and 3 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. CRISPRi screens identify the lncRNA,Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  14. Article
  15. A novelFrontiers in cellular neuroscience · 2024
    Article
  16. Article
  17. Article
  18. American journal of respiratory cell and molecular biology · 2023
    Article
  19. iScience · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Elektra K Robinson *Department of Molecular, Cell and Developmental Biology, University of California Santa Cruz, Santa Cruz, United States.ORCID 0000-0003-1427-3897
Pratibha Jagannatha *Department of Molecular, Cell and Developmental Biology, University of California Santa Cruz, Santa Cruz, United States.ORCID 0000-0003-0257-3139
Sergio CovarrubiasDepartment of Molecular, Cell and Developmental Biology, University of California Santa Cruz, Santa Cruz, United States.
Matthew CattleDepartment of Biomolecular Engineering, University of California Santa Cruz, Santa Cruz, United States.
Valeriya SmaliyDepartment of Molecular, Cell and Developmental Biology, University of California Santa Cruz, Santa Cruz, United States.
Rojin SafaviDepartment of Biomolecular Engineering, University of California Santa Cruz, Santa Cruz, United States.
Barbara ShapleighDepartment of Molecular, Cell and Developmental Biology, University of California Santa Cruz, Santa Cruz, United States.
Robin Abu-ShumaysDepartment of Biomolecular Engineering, University of California Santa Cruz, Santa Cruz, United States.
Miten JainDepartment of Biomolecular Engineering, University of California Santa Cruz, Santa Cruz, United States.
Suzanne M CloonanDivision of Pulmonary and Critical Care Medicine, Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, New York, United States.
Mark AkesonDepartment of Biomolecular Engineering, University of California Santa Cruz, Santa Cruz, United States.
Angela N BrooksDepartment of Biomolecular Engineering, University of California Santa Cruz, Santa Cruz, United States.ORCID 0000-0002-7898-3073
Susan CarpenterDepartment of Molecular, Cell and Developmental Biology, University of California Santa Cruz, Santa Cruz, United States.ORCID 0000-0002-5600-5404
University of California, Santa Cruz · USCornell University · US

Funding

A Unified Nanopore Platform for Direct Sequencing of Individual Full Length RNA Strands Bearing Modified NucleotidesR01HG010053 · NHGRI · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI AKESON, MARK A · 2018 to 2021
$3.8M
NHGRI NIH HHS R01 HG010053
6 · The paper itself

Abstract

Determining the layers of gene regulation within the innate immune response is critical to our understanding of the cellular responses to infection and dysregulation in disease. We identified a conserved mechanism of gene regulation in human and mouse via changes in alternative first exon (AFE) usage following inflammation, resulting in changes to the isoforms produced. Of these AFE events, we identified 95 unannotated transcription start sites in mice using a de novo transcriptome generated by long-read native RNA-sequencing, one of which is in the cytosolic receptor for dsDNA and known inflammatory inducible gene,

Indexed as

Alternative SplicingExons5' Untranslated RegionsAnimalsCells, CulturedDNA-Binding ProteinsGene Expression ProfilingHumansImmunity, InnateInflammationMacrophagesMicePromoter Regions, GeneticTranscriptome5' Untranslated RegionsAIM2 protein, humanAim2 protein, mouseDNA-Binding ProteinsgeneticsgenomicshumanimmunologyinflammationMacrophagesmousesplicing

Identifiers

PMID34047695
PMCPMC8260223
OpenAlexW3164313299

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.